SRPT — Sarepta Therapeutics, Inc.
Materials · Pharmaceutical Preparations · Nasdaq
4Insiders filing
4Transactions
+$0Reported buys
−$1.8MReported sells
0Cluster events
Cluster membership
| Week | Window | Tier | Dir | Insiders | Total value |
|---|---|---|---|---|---|
| 2026-W36 | 2026-09-04 → 2026-09-04 | WATCH routine | − sell | 4 | $1.8M |
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Estepan Ian Michael | Chief Operating Officer | 1 | $551k |
| Rothfuss Cristin | EVP, General Counsel | 1 | $489k |
| Rodino-Klapac Louise | President, R&D and Tech Ops | 1 | $476k |
| Wong Ryan Ho-Yan | Chief Financial Officer | 1 | $295k |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-04 | SRPT | Wong Ryan Ho-Yan Chief Financial Officer | F routine | 13,272 | $22.22 | −$295k | ✓ Cluster clu-5b5c2517621a |
| 2026-09-08 | 2026-09-04 | SRPT | Estepan Ian Michael Chief Operating Officer | F routine | 24,799 | $22.22 | −$551k | ✓ Cluster clu-5b5c2517621a |
| 2026-09-08 | 2026-09-04 | SRPT | Rothfuss Cristin EVP, General Counsel | F routine | 22,025 | $22.22 | −$489k | ✓ Cluster clu-5b5c2517621a |
| 2026-09-08 | 2026-09-04 | SRPT | Rodino-Klapac Louise President, R&D and Tech Ops | F routine | 21,423 | $22.22 | −$476k | ✓ Cluster clu-5b5c2517621a |
No transactions match these filters.